In fact, the search of the Cancer Genome Atlas (TCGA) database revealed that AML samples with high expression of Evi1 were significantly associated with low expression of EZH2, indicating a cooperative role of overexpression of Evi1 and impaired function of PRC2 in the development of AML (manuscript in submission). The gene discussed is MECOM; the disease is acute myeloid leukemia.